Guys, I don't think this has anything to do with Titomic. If you have a closer look at the announcement, the agreement is between CS and CGS-CIMBS (a Singapore investing company).
If you look at the contract, and its conditions, both the borrower AND the lender have the right to return/recall the borrowed/leased stocks early. The fact that CGS-CIMBS can recall the shares at any time with 4 business day prior notice is GREAT, this would make it more difficult for CS to manipulate the share price. I believe the slide in SP is currently not due to manipulation.
CGS-CIMBS bought TTT shares since Sept last year and has accumulated 12,681,517 shares (8.35% at that time) as of disclosure on 2nd March 2020. Everyone is required to disclose when they become a majority holder of an ASX-listed stock at more than 5% holding, and subsequent every 1% increased in holding (see https://www.clearstream.com/clearstream-en/products-and-services/market-coverage/asia-pacific/australia/disclosure-requirements-australia-1281512)
Previously, CS holds 8.33% and today 9.81% (more than 1% increase, hence the disclosure).
Since CS only borrow TTT stocks from CGS-CIMBS, this means that CGS-CIMBS has purchased an extra 2,355,483 (15,037,000 - 12,681,517) shares after their initial disclosure after becoming a major substantial holder in March 2020. Note that the current purchase of 2+ million shares by CIMBS is below the 5% threshold and thus NO disclosure to ASX is required.
In conclusion, CIMBS continues to buy shares of TTT to lend to CS. I don't think Titomic will know what CIMBS and CS are up to with their holding. Perhaps someone with better knowledge can educate us.
- Forums
- ASX - By Stock
- TTT
- Ann: Change in substantial holding
TTT
titomic limited
Add to My Watchlist
1.72%
!
28.5¢

Ann: Change in substantial holding, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $377.8M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 27.5¢ | $99.34K | 352.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 927 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 102202 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 927 | 0.285 |
3 | 100000 | 0.280 |
2 | 10643 | 0.275 |
6 | 86562 | 0.270 |
2 | 14930 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 76251 | 3 |
0.295 | 35087 | 1 |
0.310 | 23214 | 2 |
0.315 | 105000 | 2 |
0.320 | 214946 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
TTT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online